Viewing Study NCT01194960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-07-02 @ 2:05 PM
Study NCT ID: NCT01194960
Status: TERMINATED
Last Update Posted: 2020-10-19
First Post: 2010-09-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Sponsor: Oxford BioMedica
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone Refractory Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer of prostate View
None cancer of the prostate View
None neoplasms prostate View
None neoplasms prostatic View
None prostate cancer View
None prostate neoplasms View
None prostatic cancer View
None prostate specific antigen View
None prostatic hyperplasia View